Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Brainstorm Cell Therapeutics Inc
BCLICurrent price
0.37 USD
+0.02 USD (+5.78%)
Last closed
0.36 USD
Company
www.brainstorm-cell.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
27 559 178 USD
Yield for 12 month
-75.76 %
1Y
3Y
5Y
10Y
15Y
BCLI
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for other neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York. Address: 1325 Avenue of Americas, New York, NY, United States, 10019
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2.2 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
+343 000 USD
Last Quarter
–
Current Year
-265 000 USD
Last Year
-285 000 USD
Current Quarter
+277 000 USD
Last Quarter
-65 000 USD
Key Figures BCLI
1 year
3 years
5 years
10 years
EBITDA
-18 500 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-209.02 %
PEG Ratio
–
Return On Equity TTM
-1121.9 %
Wall Street Target Price
2.2 USD
Revenue TTM
–
Book Value
-0.081 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.31 USD
Diluted Eps TTM
-0.31 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics BCLI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BCLI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
16.09.2014
Dividend Date
–
Stock Valuation BCLI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-1.8838
Price Book MRQ
65.8173
Financials BCLI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BCLI
For 52 weeks
0.13 USD
1.9 USD
50 Day MA
0.44 USD
Shares Short Prior Month
890 588
200 Day MA
0.36 USD
Short Ratio
2.19
Shares Short
1 468 709
Short Percent
1.91 %
BeatStart